Pathologic Complete Response Rates in Early-Stage Human Epidermal Growth Factor 2 (HER2)-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Anti-HER2 Therapy: A Real-World Experience
新辅助化疗联合抗HER2治疗早期人表皮生长因子受体2(HER2)阳性乳腺癌的病理完全缓解率:一项真实世界研究
期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.99779
Mokfi, Rania; Boutaagount, Farah; Maskrout, Meryem; Bennour, Soundous; Senoussi, Chaymae; Nadif, Lamia; Berrada, Naoufal; Lamine, Latifa; Bouhou, Ichrak; Naciri, Sarah; Rais, Ghizlane